Literature DB >> 26472792

Simplified lipid guidelines: Prevention and management of cardiovascular disease in primary care.

G Michael Allan1, Adrienne J Lindblad2, Ann Comeau3, John Coppola4, Brianne Hudson5, Marco Mannarino6, Cindy McMinis7, Raj Padwal8, Christine Schelstraete9, Kelly Zarnke10, Scott Garrison11, Candra Cotton12, Christina Korownyk11, James McCormack13, Sharon Nickel14, Michael R Kolber11.   

Abstract

OBJECTIVE: To develop clinical practice guidelines for a simplified approach to primary prevention of cardiovascular disease (CVD), concentrating on CVD risk estimation and lipid management for primary care clinicians and their teams; we sought increased contribution from primary care professionals with little or no conflict of interest and focused on the highest level of evidence available.
METHODS: Nine health professionals (4 family physicians, 2 internal medicine specialists, 1 nurse practitioner, 1 registered nurse, and 1 pharmacist) and 1 nonvoting member (pharmacist project manager) comprised the overarching Lipid Pathway Committee (LPC). Member selection was based on profession, practice setting, and location, and members disclosed any actual or potential conflicts of interest. The guideline process was iterative through online posting, detailed evidence review, and telephone and online meetings. The LPC identified 12 priority questions to be addressed. The Evidence Review Group answered these questions. After review of the answers, key recommendations were derived through consensus of the LPC. The guidelines were drafted, refined, and distributed to a group of clinicians (family physicians, other specialists, pharmacists, nurses, and nurse practitioners) and patients for feedback, then refined again and finalized by the LPC. RECOMMENDATIONS: Recommendations are provided on screening and testing, risk assessments, interventions, follow-up, and the role of acetylsalicylic acid in primary prevention.
CONCLUSION: These simplified lipid guidelines provide practical recommendations for prevention and treatment of CVD for primary care practitioners. All recommendations are intended to assist with, not dictate, decision making in conjunction with patients. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26472792      PMCID: PMC4607330     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  33 in total

1.  Impact of comprehensive and intensive treatment of risk factors concerning cardiovascular mortality in secondary prevention: MIRVAS Study.

Authors:  Miguel A Moreno-Palanco; Patricia Ibáñez-Sanz; Cristina Ciria-de Pablo; Alberto Pizarro-Portillo; Francisco Rodríguez-Salvanés; Carmen Suárez-Fernández
Journal:  Rev Esp Cardiol       Date:  2011-02-16       Impact factor: 4.753

2.  Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative.

Authors:  Sheldon W Tobe; James A Stone; Melissa Brouwers; Onil Bhattacharyya; Kimberly M Walker; Martin Dawes; Jacques Genest; Steven Grover; Gordon Gubitz; David Lau; Andrew Pipe; Peter Selby; Mark S Tremblay; Darren E R Warburton; Richard Ward; Vincent Woo; Lawrence A Leiter; Peter P Liu
Journal:  CMAJ       Date:  2011-09-12       Impact factor: 8.262

3.  Primary prevention of cardiovascular disease with a Mediterranean diet.

Authors:  Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González
Journal:  N Engl J Med       Date:  2013-02-25       Impact factor: 91.245

4.  Contributors to primary care guidelines: What are their professions and how many of them have conflicts of interest?

Authors:  G Michael Allan; Roni Kraut; Aven Crawshay; Christina Korownyk; Ben Vandermeer; Michael R Kolber
Journal:  Can Fam Physician       Date:  2015-01       Impact factor: 3.275

Review 5.  Comparison of cardiovascular disease risk calculators.

Authors:  G Michael Allan; Scott Garrison; James McCormack
Journal:  Curr Opin Lipidol       Date:  2014-08       Impact factor: 4.776

6.  Is there time for management of patients with chronic diseases in primary care?

Authors:  Truls Østbye; Kimberly S H Yarnall; Katrina M Krause; Kathryn I Pollak; Margaret Gradison; J Lloyd Michener
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

7.  The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Authors:  Daniel G Hackam; Robert R Quinn; Pietro Ravani; Doreen M Rabi; Kaberi Dasgupta; Stella S Daskalopoulou; Nadia A Khan; Robert J Herman; Simon L Bacon; Lyne Cloutier; Martin Dawes; Simon W Rabkin; Richard E Gilbert; Marcel Ruzicka; Donald W McKay; Tavis S Campbell; Steven Grover; George Honos; Ernesto L Schiffrin; Peter Bolli; Thomas W Wilson; Ross D Feldman; Patrice Lindsay; Michael D Hill; Mark Gelfer; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Donna McLean; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Luc Trudeau; Robert J Petrella; Alain Milot; James A Stone; Denis Drouin; Kim L Lavoie; Maxime Lamarre-Cliche; Marshall Godwin; Guy Tremblay; Pavel Hamet; George Fodor; S George Carruthers; George B Pylypchuk; Ellen Burgess; Richard Lewanczuk; George K Dresser; S Brian Penner; Robert A Hegele; Philip A McFarlane; Mukul Sharma; Debra J Reid; Sheldon W Tobe; Luc Poirier; Raj S Padwal
Journal:  Can J Cardiol       Date:  2013-03-29       Impact factor: 5.223

8.  Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Thomas D Gossios; Theodora Griva; Panagiotis Anagnostis; Konstantinos Kargiotis; Efstathios D Pagourelias; Eleni Theocharidou; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Lancet       Date:  2010-11-23       Impact factor: 79.321

9.  Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.

Authors:  M de Lorgeril; S Renaud; N Mamelle; P Salen; J L Martin; I Monjaud; J Guidollet; P Touboul; J Delaye
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

10.  Agreement among cardiovascular disease risk calculators.

Authors:  G Michael Allan; Faeze Nouri; Christina Korownyk; Michael R Kolber; Ben Vandermeer; James McCormack
Journal:  Circulation       Date:  2013-04-10       Impact factor: 29.690

View more
  39 in total

1.  Is family medicine ready to look where it is heading?

Authors:  Franklin Warsh
Journal:  Can Fam Physician       Date:  2016-02       Impact factor: 3.275

2.  Prevention and management of statin adverse effects: A practical approach for pharmacists.

Authors:  Arden R Barry; Jessica E Beach; Glen J Pearson
Journal:  Can Pharm J (Ott)       Date:  2018-04-04

3.  Acetylsalicylic acid for primary prevention of cardiovascular events.

Authors:  Paul Fritsch; Michael R Kolber
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275

4. 

Authors:  Christina Korownyk; Danielle Perry; Joey Ton; Michael R Kolber; Scott Garrison; Betsy Thomas; G Michael Allan; Cheryl Bateman; Raquel de Queiroz; Dorcas Kennedy; Wiplove Lamba; Jazmin Marlinga; Tally Mogus; Tony Nickonchuk; Eli Orrantia; Kim Reich; Nick Wong; Nicolas Dugré; Adrienne J Lindblad
Journal:  Can Fam Physician       Date:  2019-05       Impact factor: 3.275

5.  Managing opioid use disorder in primary care: PEER simplified guideline.

Authors:  Christina Korownyk; Danielle Perry; Joey Ton; Michael R Kolber; Scott Garrison; Betsy Thomas; G Michael Allan; Cheryl Bateman; Raquel de Queiroz; Dorcas Kennedy; Wiplove Lamba; Jazmin Marlinga; Tally Mogus; Tony Nickonchuk; Eli Orrantia; Kim Reich; Nick Wong; Nicolas Dugré; Adrienne J Lindblad
Journal:  Can Fam Physician       Date:  2019-05       Impact factor: 3.275

6.  What's in a Number? Risk Thresholds in Different Statin Guidelines.

Authors:  Christopher J Wong; Lisa Inouye
Journal:  J Gen Intern Med       Date:  2017-06-29       Impact factor: 5.128

7.  Nonfasting lipid testing: the new standard for cardiovascular risk assessment.

Authors:  Pol Darras; Andre Mattman; Gordon A Francis
Journal:  CMAJ       Date:  2018-11-12       Impact factor: 8.262

Review 8. 

Authors:  Noah M Ivers; Maggie Jiang; Javed Alloo; Alexander Singer; Daniel Ngui; Carolyn Gall Casey; Catherine H Yu
Journal:  Can Fam Physician       Date:  2019-01       Impact factor: 3.275

Review 9.  Diabetes Canada 2018 clinical practice guidelines: Key messages for family physicians caring for patients living with type 2 diabetes.

Authors:  Noah M Ivers; Maggie Jiang; Javed Alloo; Alexander Singer; Daniel Ngui; Carolyn Gall Casey; Catherine H Yu
Journal:  Can Fam Physician       Date:  2019-01       Impact factor: 3.275

10.  Do PCSK9 inhibitors reduce cardiovascular events?

Authors:  Michael R Kolber; Tony Nickonchuk; Ricky Turgeon
Journal:  Can Fam Physician       Date:  2018-09       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.